蘇奧傳感(300507.SZ):收到小鵬及博世定點中標通知書 總金額1.17億元
格隆匯11月12日丨蘇奧傳感(300507.SZ)公佈,近日,公司收到控股子公司常州華旋的通知,常州華旋收到廣州小鵬汽車科技有限公司(簡稱“小鵬汽車”)以及羅伯特.博世有限公司(簡稱“博世”)發來的《中標通知書》。
其中,小鵬汽車某平台項目中標金額3177.09萬元人民幣;歐洲博世某平台項目中標金額8528.70萬元人民幣。上述項目中標總金額約為人民幣1.17億元人民幣,佔公司2020年度經審計營業收入的14.39%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.